ZBH Zimmer BiometcompanySEC Filings & Insider Trading Activity 2026
Latest Zimmer Biomet (ZBH) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 20, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on April 28, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Zimmer Biomet (ZBH) (SEC CIK 1136869), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model not detailed in this section; focuses on corporate governance and compliance policies
- • Adoption of Zimmer Biomet Code of Ethics for CEO and senior financial officers, publicly accessible online
Risk Factors
- • Cybersecurity risk oversight by Audit Committee with immediate escalation of material incidents to board
- • Potential operational disruption from evolving global cybersecurity threats monitored by specialized global security team
Management Discussion & Analysis
- • Revenue $8,231.5M in 2025, up 7.2% YoY from $7,678.6M, driven by Paragon 28 acquisition (+2.5%), market growth, and currency effects (+0.8%)
- • Operating margin 13.3% in 2025 vs 16.7% in 2024, decline due to inventory charges (~$170M), acquisition/integration costs, tariffs, and higher compensation
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • Revenue $2.001B Q3 2025, up 9.7% vs $1.824B Q3 2024; Nine months $5.988B, up 5.9% vs $5.655B 2024
- • Operating profit margin Q3 17.6% vs 15.3% YoY; Nine months 15.8% vs 15.9% YoY (slight decrease)
Risk Factors
- • No new or changed risk factors since 2024 Form 10-K disclosed in this 10-Q
- • Continued exposure to product liability and regulatory compliance risks from medical device industry regulations
Annual Reports Archive10-K
AI-powered analysis of Zimmer Biomet (ZBH) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Zimmer Biomet (ZBH) 10-Q quarterly reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $6.9B | $7.4B | $7.7B | $8.2B |
| Operating Income | $696.3M | $1.3B | $1.3B | $1.1B |
| Net Income | $231.4M | $1.0B | $903.8M | $705.1M |
| Op. Margin | 10.0% | 17.3% | 16.7% | 13.3% |
| Net Margin | 3.3% | 13.8% | 11.8% | 8.6% |
| Balance Sheet | ||||
| Total Assets | $21.1B | $21.5B | $21.4B | $23.1B |
| Equity | $12.0B | $12.5B | $12.5B | $12.7B |
| ROE | 1.9% | 8.2% | 7.2% | 5.6% |
Source: XBRL financial data from Zimmer Biomet (ZBH) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 28, 2026 | — | — | — |
8-K | Apr 28, 2026 | — | — | — |
10-K | Feb 20, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 10, 2026 | — | — | |
8-K | Jan 12, 2026 | — | — | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 5, 2025 | Mar 31, 2025 | Analysis | |
10-K | Feb 25, 2025 | Dec 31, 2024 | Analysis | |
10-Q | Oct 30, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | — | |
10-Q | May 2, 2024 | Mar 31, 2024 | — | |
10-K | Feb 23, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 1, 2023 | Jun 30, 2023 | — | |
10-Q | May 2, 2023 | Mar 31, 2023 | — | |
10-K | Feb 24, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 2, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 2, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Feb 25, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 4, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 3, 2021 | Jun 30, 2021 | — | |
10-Q | May 4, 2021 | Mar 31, 2021 | — | |
10-K | Feb 22, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest ZBH SEC filings in 2026?
Zimmer Biomet (ZBH) has filed a 10-K annual report on February 20, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on April 28, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ZBH file its most recent 10-K annual report?
Zimmer Biomet (ZBH) filed its most recent 10-K annual report on February 20, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ZBH 10-Q quarterly reports?
Zimmer Biomet (ZBH)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every ZBH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ZBH filed recently?
Zimmer Biomet (ZBH)'s most recent 8-K was filed on April 28, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ZBH insider trading activity (Form 4)?
SignalX aggregates every ZBH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ZBH file with the SEC?
Zimmer Biomet (ZBH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ZBH filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Zimmer Biomet (ZBH).
What is ZBH's SEC CIK number?
Zimmer Biomet (ZBH)'s SEC CIK (Central Index Key) number is 1136869. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1136869 to look up all ZBH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ZBH return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Zimmer Biomet (ZBH) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Zimmer Biomet SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 40+ filings.